RankAlpha logo
Back to Rankings

VMD

Viemed HealthcareB
Nasdaq / Health Care Equipment & Services
Last Price
At close
2026-06-02
View Chart
Current thesis
The best post-print bull read is that Q1 validated the March setup: revenue grew 28%, free cash flow improved, capital intensity guidance moved lower, and revenue guidance was narrowed upward. Continued execution in sleep, resupply, maternal health, and stable ventilation can support a rerating from a still-small-cap multiple base.
Posture
Constructive
Lead driver
Momentum
What changed
Momentum remains the lead driver in the composite, 7D delta -2.0.
What can break
Adjusted EBITDA guidance was reaffirmed rather than raised, so margin conversion still needs proof even after the revenue guide moved higher.
Momentum
73
Value
61
Sentiment
49
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $10.40 · Bull $13.10 · Bear $7.40
Data freshness
Prices
As of 2026-06-02
Fundamentals
As of 2026-06-01 • Vendor: Data Vendor v1
Scores
As of 2026-06-02 • Model: HYBRID_IC_RP
AI Memo
As of 2026-05-08 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-06-02
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $13.10
Why
Momentum73 · Δ7d -2.0
Value61 · Δ7d +0.0
Sentiment49 · Δ7d +2.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Lead driver: Momentum · See technicals
Momentum
73
34% active weight
Current posture
7d trendSoftening
Δ7d
-2.0
Δ21d
+5.6
Value
61
32% active weight
Current posture
7d trendFlat
Δ7d
+0.0
Δ21d
+0.0
Sentiment
49
33% active weight
Current posture
7d trendImproving
Δ7d
+2.4
Δ21d
+0.1
Why this grade

Composite grade B. Momentum 73.0 / Value 60.6 / Sentiment 49.4

Fundamentals (TTM)
As of 2026-06-01
Market Cap
$372.63M
Beta
1.27
Shares Out
38.02M
P/E (TTM)
21.9
P/S (TTM)
1.08
P/FCF (TTM)
51.26
Rev YoY
+24.0%
EPS YoY
-8.8%
Gross Margin
+57.9%
Op Margin
+8.3%
Net Debt
-$13.49M
Current Ratio
1.13
As of 2026-06-02 • Updated nightlySource: Internal modelMethodology